To utilize Bifidobacterium longum (B. longum) as a safe and stable delivery system for endostatin in cancer gene therapy, we constructed pBV22210 vector combining a chloramphenicol-resistance gene (Cm r ) from pBCSK( þ ) plasmid, a cryptic plasmid pMB1 from B. longum strain with pBV222. Endostatin was cloned directly downstream of an N terminal His6-tag sequence in the pBV22210, so that the endostatin protein expressed in B. longum could be purified with Ni-binding resin. The results indicated that the plasmid electroporated into B. longum was maintained stably in the absence of selective antibiotics and did not significantly affect biological characteristics of B. longum. In addition, the plasmid in B. longum showed a strong inhibitory effect on the growth of mouse solid liver tumor in vivo. These results suggested that this new plasmid may be a stable vector in B. longum for transporting anti-cancer genes in cancer gene therapy.
Introduction
Bifidobacterium longum has numerous characteristics that make it as an interesting host cell for heterologous protein production. It is one of the nonpathogenic normal bacterial florae in the intestine and can defend the host against viral infection. More importantly, it can selectively grow in the hypoxic regions of solid tumors following intravenous injection. 1 In the past years, some B. longum-E coli shuttle vectors have been constructed by using a Bifidobacterium-derived plasmid and a foreign antibiotic resistance gene as a selection marker, such as the shuttle vector pRM2, pNC7 or pDG7 derived from the plasmid pMB1. [2] [3] [4] [5] And, the other two Bifidobacteriumderived plasmids, pBKJ50F and pBKJ50R were constructed based on plasmid pKJ50 of B. longum KJ. 6 These plasmids, however, could not express foreign gene in Bifidobacterium, which hampered broader application of Bifidobacterium as a specific gene delivery system for cancer gene therapy although successful expressions of foreign gene in the Bifidobacterium have been reported. [7] [8] [9] [10] [11] Our previous studies demonstrated that pBV220, an E. coli-derived vector, could express foreign gene in B. adolescentis and B. longum. 9, 10 However, it was found to be unstable in Bifidobacterium in the absence of selective antibiotics, which was particularly disadvantageous for prolonged and large-scale cultivation of the plasmid-bearing cells. Therefore, in the present study, we developed a shuttle vector, which could replicate in both Escherichia coli and B. longum and expressed a target gene in B. longum. The recombinant plasmid in the B. longum showed a strong inhibitory effect on the growth of mouse solid liver tumor in vivo.
Materials and methods
Bacterial strains and plasmids E. coil strain DH5a was preserved in our laboratory; wildtype B. longum was obtained from Chinese IFFI Microbial Center (Beijing, China). Plasmid pDG7 which contained pMB1 was a gift from Professor Diego Matteuzzi (University of Bologna, Bologna, Italy); pBCSK( þ ) contained Cm r was provided generously by Dr Ming Li (Nanjing Agricultural University, Nanjing, China); and pBV222 was from Institute of Virology, Chinese Academy of Preventive Medicine (Beijing, China).
Animals and tumors
Male Kunming mice (2072 g) were obtained from Animal Center of Nanjing Medical University (Nanjing, China). The animals were maintained in a specific pathogen-free environment and cared in accordance with the institutional guidelines. Murine hepatoma cells (H22) were obtained from the Laboratory Animal Center, Chinese Academy of Sciences (Shanghai, China). Liver tumor model was established by subcutaneously injection of H22 tumor cells (1 Â 10 6 cells/0.2 ml) into the flank of each mouse. [12] [13] [14] Reagents and enzymes Pwo DNA polymerase, T 4 DNA ligase, Klenow enzyme and restrictive endonucleases were purchased from New England BioLabs (Hertfordshire, UK). Monoclonal mouse anti-human endostatin antibody was obtained from Oncogene Research Products (San Diego, USA). Goat anti-mouse IgG was purchased from Sino-American Biotechnology (Shanghai, China). Primers were synthesized by Sangon (Shanghai, China).
Construction of the expression vector
Standard methods were used for DNA isolation and recombination. PCR was performed using Pwo polymerase according to the manufacturer's instructions. Strategies for constructing plasmids were as follows:
(i) pBV222-Cm r : A gel-purified Bpu10I (blunted with Klenow) restricted fragment of pBCSK( þ ) containing Cm r was ligated into MunI (blunted) site of pBV222, yielding pBV222-Cm r (ii) pBV22210: The pMB1 genes were amplified by PCR from pDG7 using the primers A1 (5 0 -CCGCCATT CAGGCCATCTGACCGCACGCGAACGCCATC CGGTTCATCG-3 0 ) and A2 (5 0 -CCGCCATTCAGG CTCAGTCGAACAGTGGAATCTCGCCGGG-3 0 ). The resulting PCR product was digested with BglI and ligated into pBV222-Cm r digested with BglI, resulting pBV22210 vector. (iii) pBV22210-Endo: Human endostatin gene was obtained by PCR method from human liver cDNA library (Clontech, Franklin Lakes, NJ, USA) using the primers B1 (5 0 -CCGGAATTCCACAGCCACC GCGACTTCCAG-3 0 ) and B2 (5 0 -GCCGGATCCC TAGCGGCGGCGGCGGCGGCGGCGGCGGCG CTTGGAGGCAGTCATGAA GC-3 0 ). The primers was linked a cell gate, made up of a repeating series of up to nine arginine amino acids in C terminal. The PCR product was digested with EcoRI/BamHI and ligated into the EcoRI/BamHI site of pBV22210, yielding pBV22210-Endo (Figure 1 ). The pBV22210-Endo plasmid contained a replicon of E. coli, a replicon of B. longum and chloramphenicol (CM) resistance gene. (iv) pBV222-Endo: The same EcoRI-/BamHI-digested endostatin gene PCR product was similarly cloned into the EcoRI/BamHI site of pBV222 vector, yielding pBV222-Endo. The pBV222-Endo plasmid contained a replicon of E. coli and ampicillinresistance gene.
Electroporation
Electrocompetent cells of B. longum were prepared according to Rossi et al. 3 The pBV22210-Endo and pBV222-Endo plasmids were transferred directly into B. longum by electroporation in a Bio-Rad Gene-Pulser apparatus at 25 mF and 1.25 kV with the pulse controller set at 200 O. Transformed B. longum was plated on TPY agar plates containing 0.5 M sucrose and 5 mg/ml CM. After 3 to 5 days of incubation at 371C under anaerobic conditions and transformants of B. longum with pBV22210-Endo (B. longum-pBV22210-Endo) and B. longum with pBV222-Endo (B. longum-pBV222-Endo) could be detected.
Morphology
The B. longum-pBV22210-Endo and wild-type B. longum cells were grown in TPY medium to an exponential phase, harvested by centrifugation, washed twice with 0.1 M PBS (pH 7.0). The cells were stained with Gram stain reagent and viewed using the Â 400 objective of an Olympus BH-2 light microscope.
Antibiotic resistance and biochemical characteristics
Antibiotics susceptibility of B. longum cells was detected by disc agar diffusion technique. The B. longumpBV22210-Endo and wild-type B. longum were uniformly streaked over the entire surface of TYP solid medium, An endostatin gene expression plasmid in B. longum Y-F Xu et al then different antibiotics paper discs were placed on the surface of the above plates. After anaerobic incubation at 371C for 72 h, the zone of inhibition around each of the discs was measured. The carbohydrates fermentation was determined on TPY broth containing bromocresol purple (0.04 g/l) as a pH indicator, and supplemented with different carbon source. 9 B. longum-pBV22210-Endo and wild-type B. longum were inoculated into the above medium. After anaerobic incubation at 371C for 8 days, they were detected by the color of indicator.
Growth assay B. longum-pBV22210-Endo cells were grown overnight in TPY medium. The saturated cultures were inoculated into fresh medium with (5 mg/ml) and without CM to an initial optical density values of 0.016 at 600 nm (OD 600). Cultures were grown at 371C under anaerobic conditions for 24 h, then the OD value was measured every 1 h.
Plasmid stability assay B. longum-pBV22210-Endo and B. longum-pBV222-Endo were grown in TPY medium without selective pressure, and the samples were taken at intervals from the continuous cultures. After appropriate dilutions were made, 100 ml of each sample was plated on TPY agar plates without antibiotic, one hundred single colonies were picked from the TPY agar and planted on other TPY agar plates with (5 mg/ml) and without CM, respectively. Bacterial colonies were estimated after anaerobic incubation at 371C for 3 d. The plasmid stability was expressed as the ratio between the number of colonies formed on plates with (5 mg/ml) and without CM.
Expression, affinity purification and detection of endostatin protein in B. longum B. longum-pBV22210-Endo cells were grown aerobically at 301C in 0.5 l of TPY medium to an OD600 reached 0.4-0.6, when expression was induced at 421C for a further 6 h. Cells were harvested by centrifugation, resuspended in buffer Z (8 M Urea, 100 mM NaCl, 20 mM HEPES, pH 8.0) plus 40 mg/ml lysozyme and sonicated to break up the cells. After centrifugation, the supernatant was mixed with Ni-binding resin that had been previously equilibrated with buffer Z. The mixture was incubated overnight at 41C under continuously agitation and subsequently poured into a Bio-spin column (Bio-Rad, USA). The column was washed with 20 column volumes of buffer Z. The His6-tag fusion protein was eluted with buffer Z containing 500 mM imidazole. The purification was assayed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis.
Suppression of H22 tumors growth by treatment of B. longum-pBV22210-Endo After H22 tumor cells were incubated for 24 h, the tumorbearing mice were randomly divided into four groups (eight mice per group). One negative control group was injected with 5% glucose in 0.9% NaCl, and three treatment groups were injected, respectively, with B. longum-pBV22210-Endo, B. longum-pBV222-Endo and wild-type B. longum cells. Before injection, all cells were washed three times and resuspended with 5% glucose in 0.9% NaCl at a concentration of 2.5 Â 10 8 cells/ml. Each mouse was injected intravenously via the tail vein at a dose of 0.4 ml of the above suspension and carried out once each day for 7 days continuously. After additional 3 days following the treatment, the mice were killed, and the tumors were excised, weighted and the volumes were measured according to the formula: tumor volume ¼ (width) 2 Â length Â 0.52. 15 The level of inhibition of tumor growth was determined by the formula as follows:
tumor
Statistical analysis
Statistical evaluations of numerical variables were performed using Student's t-test in both groups and ANOVA test in multiple groups. The multiple comparisons among groups were performed using Student-Newman-Keuls q-test. Significance was defined as Po0.05. Antibiotic resistance and biochemical characteristics There were common characteristics between B. longumpBV22210-Endo and wild-type B. longum cells in carbohydrates fermentation, except for the following three carbohydrates: salicin, mannose and melezitose. Contrary to wild-type B. longum, B. longum-pBV22210-Endo cells fermented salicin and mannose but not melezitose (Table 1) . Except for CM, B. longum-pBV22210-Endo and wild-type B. longum cells showed no significant difference in the other antibiotic susceptibility (Table 2) .
Results

Morphological and biochemical characteristics
Growth assay
The growth rates for B. longum-pBV22210-Endo and wild-type B. longum cells were statistically similar in TPY medium without selective pressure (Figure 3 ). Both cultures grew to an exponential phase after 7 h of incubation and reached stationary phase (OD600 of 1.1) after 10 h of incubation. However, the lag phase of B. longum-pBV22210-Endo in selective medium was statistically longer than the lag phase of B. longum-pBV22210-Endo and wild-type B. longum in nonselective medium.
B. longum-pBV22210-Endo cells grew to an exponential phase after 15 h and stationary phase after 18 h in TPY medium with CM (5 mg/ml).
Plasmid stability assay B. longum cells harboring pBV222-Endo and pBV22210-Endo were cultivated for 72 h under nonselective growth conditions. Almost 50% of the cells harboring pBV22210-Endo retained the plasmid. In the case of pBV222-Endo, only 5% of the cells retained the plasmid (Figure 4) . Furthermore, B. longum cells harboring pBV22210-Endo could be cultivated for 50 generations in CM medium, while B. longum cells harboring pBV222-Endo could be cultivated for 10 generations in ampicillin medium. The results showed that plasmid pBV22210-Endo was much more stable when grown in selective medium than pBV222-Endo in B. longum.
Expression of endostatin in B. longum
By taking advantage of the endostatin expressed from pBV22210-Endo in B. longum containing an N terminal His6-tag, the recombinant protein in whole-cell lysates of heat induced B. longum-pBV22210-Endo cells was purified by affinity chromatography over Ni-nitriloacetic acidagarose column. After affinity purification was carried out, we performed Western blot analysis using monoclonal mouse anti-human endostatin antibody. As shown in Figure 5 , a prominent band of about 22 kDa corresponding to the size of the endostatin-His6-tag was observed in B. longum-pBV22210-Endo cells, and no similar band was observed in wide-type B. longum cells.
Suppression of H22 tumors growth by treatment of B. longum-pBV22210-Endo
We investigated the anti-tumor efficacy of B. longumpBV22210-Endo cells. The mean tumor weight and tumor volume were shown in Figure 6 . Compared with 5% glucose in 0.9% NaCl group, B. longum-pBV22210-Endo cells significantly inhibited the tumor growth in both tumor weight (by 61.47%) and tumor volume (by 51.05%) with P ¼ 0.000136 and 0.0000243, respectively. Compared with wild-type B. longum, B. longumpBV22210-Endo cells significantly inhibited the tumor Figure 2 Morphological characteristics of B. longum-pBV22210-Endo (a) or wild-type B. longum cells (b). Â 400. growth in both tumor weight (by 46.24%) and tumor volume (by 41.12%) with P ¼ 0.00435 and 0.00408, respectively. Although B. longum-pBV22210-Endo cells showed stronger inhibitory effects on the tumor weight (by 20.51%) and tumor volume (by 13.08%), the effects were not statistically significant in comparison with that of B. longum-pBV222-Endo (P ¼ 0.186 and 0.397).
Discussion
Plasmid instability is a major problem in continuous culture through many generations. The resulting effects are lower productivity and increase in production cost, because of the build-up of non-productive plasmid-free cells. This study constructed a stable vector pBV22210-Endo encoding endostatin gene in B. longum, and the expressed recombinant protein effectively inhibited the growth of mouse solid liver tumor in vivo. The vector pBV22210-Endo studied contained a chloramphenicolresistance gene (Cm r ) and the cryptic plasmid pMB1 derived from B. longum.
The presence of a selection marker allows for identifying the transformed clones and the stable maintenance of the plasmid if a selective pressure is imposed. Some authors have reported that CM, spectinomycin or erythromycin resistance gene could serve as a selection marker in Bifidobacterium-E.coli transformation systems. [2] [3] [4] 6 Most used the Cm r as a selection maker gene, which was probably due to CM treatment inhibited chromosomal but not plasmid replication. The vector pBV222 contained only an ampicillin-resistance gene. However, ampicillin is an inhibitor of bacterial cell wall synthesis resulting in lysis or deformation of the bacterium and inhibits the crosslinking of peptidoglycan by binding and inactivating transpeptidases. Therefore, ampicillin is harmful to bacterial cell wall synthesis after electroporation and bacterial growth. Antibiotics susceptibility of B. longum cells detected in this study showed that it was resistant to ciprofloxacin and susceptible to CM (Table 2) . Therefore, the Cm r was used as the selection maker gene in this study.
The vector pBV222 that only contained a replicon of E. coli was highly unstable in B. longum. Therefore, a replicon derived from Bifidobacterium itself is necessary for construction of the stable expressing vector in B. longum. It was reported that seven plasmids from Bifidobacterium have been completely sequenced: p4M from B. pseudocatenulatum, 16 pAP1 from B. asteroides, 17 pCIBb1 from B. breve, 18 pKJ36 and pKJ50 from B. longum, 19 pTB6 from B. longum 20 and pMB1 from B. longum. Based on B. longum plasmid pMB1, some shuttle vectors were constructed, and it was found that no structural instability was observed for any of the shuttle vectors in B. animalis ATCC 27536. 21 In this study, we selected pMB1 as the source of replicon to construct pBV22210-Endo, and the results showed that it could be stably copied in B. longum. The pMB1 was a cryptic plasmid in B longum B2577 and contained two open reading frames, orf1 and orf2 which were required for plasmid replication. 5 The vector pBV22210-Endo did not significantly affect the biological characteristics of B. longum. Compared to Tables 1 and 2 . Zhu et al. 22 reported that the fermentation of L-arabinose, gluconate, inulin, lactose, D-mannose, methyl a-D-glucoside, ribose, salicin, trehalose or xylose was variable. 22 The B. longum-pBV22210-Endo cells were sensitive to ampicillin and resistant to CM, as the Cm r replaced the ampicillin resistance gene as the selection marker in the recombinant plasmid. Owing CM inhibition of the spread of bacteria by interfering with protein synthesis in bacterial cells and preventing them from multiplying, B. longum-pBV22210-Endo cells grew more slowly in TPY medium with CM than that without CM. Thus, B. longum-pBV22210-Endo cells were not significantly different from wide-type B. longum in morphological, biochemical and growth characteristics.
In this study, endostatin was cloned directly downstream of an N terminal His6-tag sequence in the pBV22210, the endostatin expressed from pBV22210-Endo in B. longum carried a His6-tag, which allowed purification by affinity chromatography using Ni-binding resin. Although the protein expression was not as efficient as in E. coli, the insertion of a strong bifidobacterial promoter into the vectors may help to increase expression levels.
Wild-type B. longum had tumor growth inhibitory activity, but the activity was much lower than that of B. longum-pBV22210-Endo or B. longum-pBV222-Endo cells that can express endostatin ( Figure 6 ). Endostatin has been found to inhibit the subcutaneous growth of primary tumors. 23 In addition, a 27-amino acid peptide corresponding to the N terminal domain of endostatin also possessed anti-tumor activity. 24 Moreover, the C terminal of endostatin gene was conjugated with a nonamer of arginine through PCR-amplifying in this study. It has been reported that various argininerich peptides could enhance delivery of poorly absorbed drugs across tissue barriers. 25 Therefore, full-length endostatin, peptides derived from endostatin and endostatin modified by nonamer of arginine may facilitate the delivery of the target agents and thus improve the efficacy in the inhibition of tumor growth. Our present in vivo assessment of inhibition on tumor growth of B. longum-pBV22210-Endo cells had significant effect on the inhibition of tumor growth and had higher activity compared to B. longum-pBV222-Endo cells ( Figure 6 ).
In conclusion, our results demonstrated that pBV22210-Endo was more stable in B. longum under nonselective growth conditions compared with pBV222-Endo and showed an ability to inhibit tumor growth. The plasmid pBV22210 may be used as a new expression vehicle in B. longum as a delivery system of extraneous proteins for cancer gene therapy, preparing food additives or oral vaccine. 
